Brief: Astrazeneca Pharma India Sept-Quarter PAT 542.2 Million Rupees
07/11/2025 12:24
Nov 7 (Reuters) - Astrazeneca Pharma India ASTR.NS: SEPT-QUARTER PAT 542.2 MILLION RUPEES SEPT-QUARTER REVENUE FROM OPERATIONS 5.59 BILLION RUPEES Source text: [ID:] Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication